{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:01:08Z","timestamp":1792101668296,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funda\u00e7\u00e3o Arauc\u00e1ria\u2014Governo do Estado do Paran\u00e1"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.brainres.2014.09.068","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T22:18:08Z","timestamp":1412720288000},"page":"95-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats"],"prefix":"10.1016","volume":"1593","author":[{"given":"Taysa B.","family":"Bassani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa W.","family":"Gradowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Zaminelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana\u00edna K.","family":"Barbiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronise M.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suelen L.","family":"Boschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.S.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.B.F.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2014.09.068_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease\u2014epidemiology, mechanisms and management","volume":"8","author":"Aarsland","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2014.09.068_bib2","first-page":"23","article-title":"Melatonin is protective against MPTP-induced striatal and hippocampal lesions","volume":"60","author":"Acu\u00f1a-Castroviejo","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2014.09.068_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0006-8993(02)02551-9","article-title":"Protective effect of melatonin in a chronic experimental model of Parkinson\u05f3s disease","volume":"943","author":"Antol\u00edn","year":"2002","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.brainres.2014.09.068_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u05f3s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2014.09.068_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2010.04.011","article-title":"Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test","volume":"638","author":"Binfar\u00e9","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.brainres.2014.09.068_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","article-title":"Study of circadian melatonin secretion pattern at different stages of Parkinson\u05f3s disease","volume":"26","author":"Bordet","year":"2003","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainres.2014.09.068_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u05f3s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.brainres.2014.09.068_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.brainres.2014.09.068_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2009.03.006","article-title":"Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson\u05f3s disease","volume":"218","author":"B\u00fceler","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2014.09.068_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2008.07.022","article-title":"Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats","volume":"594","author":"Capitelli","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2014.09.068_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u05f3s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2014.09.068_bib12","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1523\/JNEUROSCI.2993-04.2004","article-title":"Chronic exposure to rotenone models sporadic Parkinson\u05f3s disease in Drosophila melanogaster","volume":"24","author":"Coulom","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2014.09.068_bib13","first-page":"77","article-title":"The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson\u05f3s disease","volume":"113","author":"Datieva","year":"2013","journal-title":"Zhurnal Nevrol. Psikhiatrii Im. SS Korsakova"},{"key":"10.1016\/j.brainres.2014.09.068_bib14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u05f3s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2014.09.068_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2009.02.037","article-title":"Antidepressant-like effects of melatonin in the mouse chronic mild stress model","volume":"607","author":"Detanico","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2014.09.068_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pneurobio.2010.12.004","article-title":"Melatonin\u2014a pleiotropic, orchestrating regulator molecule","volume":"9","author":"Hardeland","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2014.09.068_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson\u05f3s disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2014.09.068_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12017-012-8214-x","article-title":"A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson\u05f3s disease","volume":"15","author":"Hayashi","year":"2013","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.brainres.2014.09.068_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(98)00170-0","article-title":"Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats","volume":"245","author":"Jin","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2014.09.068_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2014.00162","article-title":"Links between circadian rhythms and psychiatric disease","volume":"8","author":"Karatsoreos","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2014.09.068_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/07420528.2011.649870","article-title":"Circadian dysfunction in a rotenone-induced Parkinsonian rodent model","volume":"29","author":"Lax","year":"2012","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.brainres.2014.09.068_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.brainres.2014.09.068_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lfs.2013.01.007","article-title":"Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson\u05f3s disease","volume":"92","author":"Lin","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2014.09.068_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2013.12.021","article-title":"Serum melatonin is an alternative index of Parkinson\u05f3s disease severity","volume":"1547","author":"Lin","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2014.09.068_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2009.08.001","article-title":"The influence of microglia on the pathogenesis of Parkinson\u05f3s disease","volume":"89","author":"Long-Smith","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2014.09.068_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","article-title":"Does melatonin help save dopaminergic cells in MPTP-treated mice?","volume":"15","author":"Ma","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2014.09.068_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","article-title":"Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway","volume":"343","author":"Mantovani","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2014.09.068_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0306-9877(90)90097-X","article-title":"The therapeutic potential for tryptophan and melatonin: possible roles in depression, sleep, Alzheimer\u05f3s disease and abnormal aging","volume":"31","author":"Maurizi","year":"1990","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.brainres.2014.09.068_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neulet.2007.04.029","article-title":"Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells","volume":"419","author":"McMillan","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2014.09.068_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","article-title":"Effects of exogenous melatonin on sleep and motor dysfunction in PD: a randomized, double-blind, placebo controlled study","volume":"254","author":"Medeiros","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2014.09.068_bib31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.euroneuro.2006.01.005","article-title":"Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission","volume":"16","author":"Micale","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2014.09.068_bib32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1734-1140(12)70905-2","article-title":"Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration","volume":"64","author":"Morais","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.brainres.2014.09.068_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12640-011-9278-3","article-title":"Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin","volume":"21","author":"Moreira","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainres.2014.09.068_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","article-title":"Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes","volume":"23","author":"Pandi-Perumal","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainres.2014.09.068_bib35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.pbb.2011.06.026","article-title":"Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson\u05f3s disease","volume":"99","author":"Patki","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2014.09.068_bib36","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.21542","article-title":"Bright light therapy in PD: a pilot study","volume":"22","author":"Paus","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2014.09.068_bib37","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.brainres.2014.09.068_bib38","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S1353-8020(09)70841-7","article-title":"Dopamine receptor agonists and depression in Parkinson\u05f3s disease","volume":"15S","author":"Picillo","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2014.09.068_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioral despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2014.09.068_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0924-977X(00)00115-2","article-title":"Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation","volume":"10","author":"Raghavendra","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2014.09.068_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-4328(02)00203-6","article-title":"In the rat forced swimming test, chronic but not subacute administration of dual 5-HT\/NA antidepressant treatments may produce greater effects than selective drugs","volume":"136","author":"Reneric","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2014.09.068_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","article-title":"Oxidative damage to macromolecules in human Parkinson disease and the rotenone model","volume":"62","author":"Sanders","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2014.09.068_bib43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u05f3s disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2014.09.068_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2006.00412.x","article-title":"Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model","volume":"42","author":"Saravanan","year":"2007","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.brainres.2014.09.068_bib45","first-page":"257","article-title":"Central nervous system depressant activities of melatonin in rats and mice","volume":"36","author":"Shaji","year":"1998","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.brainres.2014.09.068_bib46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","article-title":"Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson\u05f3s disease","volume":"1068","author":"Sharma","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2014.09.068_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and \u03b1-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2014.09.068_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12035-011-8225-x","article-title":"Melatonin as a neuroprotective agent in the rodent models of Parkinson\u05f3s disease: is it all set to irrefutable clinical translation?","volume":"45","author":"Singhal","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2014.09.068_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson\u05f3s disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2014.09.068_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2012.08.018","article-title":"Circadian and sleep disorders in Parkinson\u05f3s disease","volume":"243","author":"Videnovic","year":"2013","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.brainres.2014.09.068_bib51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0031-9384(99)00023-2","article-title":"A therapeutic role for melatonin antagonism in experimental models of Parkinson\u05f3s disease","volume":"66","author":"Willis","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2014.09.068_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pbb.2004.08.011","article-title":"Recovery of experimental Parkinson\u05f3s disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor","volume":"79","author":"Willis","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2014.09.068_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2004.10.022","article-title":"Recovery from experimental Parkinson\u05f3s disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23","volume":"80","author":"Willis","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2014.09.068_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.brainres.2008.03.083","article-title":"Intraocular microinjections repair experimental Parkinson\u05f3s disease","volume":"1217","author":"Willis","year":"2008","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.brainres.2014.09.068_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/revneuro-2011-0072","article-title":"A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson\u05f3s disease","volume":"23","author":"Willis","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.brainres.2014.09.068_bib56","first-page":"3291","article-title":"Parkinson\u05f3s disease, lights and melanocytes: looking beyond the retina","volume":"4","author":"Willis","year":"2014","journal-title":"Sci. Rep. Nat."},{"key":"10.1016\/j.brainres.2014.09.068_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2013.01.014","article-title":"Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson\u05f3s disease: insights from a transgenic mouse model","volume":"243","author":"Willison","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2014.09.068_bib58","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-079X.2011.00926.x","article-title":"Melatonin protects against rotenone-induced cell injury via inhibition of Omi and Bax-mediated autophagy in Hela cells","volume":"52","author":"Zhou","year":"2012","journal-title":"J. Pineal Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899314013419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899314013419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T14:55:41Z","timestamp":1538146541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899314013419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":58,"alternative-id":["S0006899314013419"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2014.09.068","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2014.09.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}